LIST OF EXHIBITS
Exhibit 1: HISTORIC & PROJECTED VOLUME OF INCIDENCE & PREVALENCE OF ULCERATIVE COLITIS IN 8 MAJOR MARKETS (2018 – 2027)
Exhibit 2: COMPARATIVE ANALYSIS OF INCIDENCE & PREVALENCE OF ULCERATIVE COLITIS IN 8 MAJOR MARKETS (2018 – 2020)
Exhibit 3: COMPARATIVE ANALYSIS OF INCIDENCE & PREVALENCE OF ULCERATIVE COLITIS IN 8 MAJOR MARKETS (2021 – 2027)
Exhibit 4: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY DISEASE TYPE IN 8 MAJOR MARKETS (2018 – 2027)
Exhibit 5: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY SEVERITY TYPE IN 8 MAJOR MARKETS (2018 – 2027)
Exhibit 6: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY AGE GROUP IN 8 MAJOR MARKETS (2018 – 2027)
Exhibit 7: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY GENDER TYPE IN 8 MAJOR MARKETS (2018 – 2027)
Exhibit 8: HISTORIC & PROJECTED VOLUME OF PREVELANCE OF ULCERATIVE COLITIS BY DISEASE TYPE IN 8 MAJOR MARKETS (2018 – 2027)
Exhibit 9: HISTORIC & PROJECTED VOLUME OF PREVALENCE OF ULCERATIVE COLITIS BY SEVERITY TYPE IN 8 MAJOR MARKETS (2018 – 2027)
Exhibit 10: HISTORIC & PROJECTED VOLUME OF PREVALENCE OF ULCERATIVE COLITIS BY AGE GROUP IN 8 MAJOR MARKETS (2018 – 2027)
Exhibit 11: HISTORIC & PROJECTED VOLUME OF PREVALENCE OF ULCERATIVE COLITIS BY GENDER TYPE IN 8 MAJOR MARKETS (2018 – 2027)
Exhibit 12: HISTORIC & PROJECTED VOLUME OF INCIDENCE & PREVALENCE OF ULCERATIVE COLITIS IN US (2018 – 2027)
Exhibit 13: COMPARATIVE ANALYSIS OF INCIDENCE & PREVALENCE OF ULCERATIVE COLITIS IN US (2018 – 2020)
Exhibit 14: COMPARATIVE ANALYSIS OF INCIDENCE & PREVALENCE OF ULCERATIVE COLITIS IN US (2021 – 2027)
Exhibit 15: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY DISEASE TYPE IN US (2018 – 2027)
Exhibit 16: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY SEVERITY TYPE IN US (2018 – 2027)
Exhibit 17: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY AGE GROUP IN US (2018 – 2027)
Exhibit 18: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY GENDER TYPE IN US (2018 – 2027)
Exhibit 19: HISTORIC & PROJECTED VOLUME OF PREVELANCE OF ULCERATIVE COLITIS BY DISEASE TYPE IN US (2018 – 2027)
Exhibit 20: HISTORIC & PROJECTED VOLUME OF PREVALENCE OF ULCERATIVE COLITIS BY SEVERITY TYPE IN US (2018 – 2027)
Exhibit 21: HISTORIC & PROJECTED VOLUME OF PREVALENCE OF ULCERATIVE COLITIS BY AGE GROUP IN US (2018 – 2027)
Exhibit 22: HISTORIC & PROJECTED VOLUME OF PREVALENCE OF ULCERATIVE COLITIS BY GENDER TYPE IN US (2018 – 2027)
Exhibit 23: HISTORIC & PROJECTED VOLUME OF INCIDENCE & PREVALENCE OF ULCERATIVE COLITIS IN CHINA (2018 – 2027)
Exhibit 24: COMPARATIVE ANALYSIS OF INCIDENCE & PREVALENCE OF ULCERATIVE COLITIS IN CHINA (2018 – 2020)
Exhibit 25: COMPARATIVE ANALYSIS OF INCIDENCE & PREVALENCE OF ULCERATIVE COLITIS IN CHINA (2021 – 2027)
Exhibit 26: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY DISEASE TYPE IN CHINA (2018 – 2027)
Exhibit 27: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY SEVERITY TYPE IN CHINA (2018 – 2027)
Exhibit 28: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY AGE GROUP IN CHINA (2018 – 2027)
Exhibit 29: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY GENDER TYPE IN CHINA (2018 – 2027)
Exhibit 30: HISTORIC & PROJECTED VOLUME OF PREVELANCE OF ULCERATIVE COLITIS BY DISEASE TYPE IN CHINA (2018 – 2027)
Exhibit 31: HISTORIC & PROJECTED VOLUME OF PREVALENCE OF ULCERATIVE COLITIS BY SEVERITY TYPE IN CHINA (2018 – 2027)
Exhibit 32: HISTORIC & PROJECTED VOLUME OF PREVALENCE OF ULCERATIVE COLITIS BY AGE GROUP IN CHINA (2018 – 2027)
Exhibit 33: HISTORIC & PROJECTED VOLUME OF PREVALENCE OF ULCERATIVE COLITIS BY GENDER TYPE IN CHINA (2018 – 2027)
Exhibit 34: HISTORIC & PROJECTED VOLUME OF INCIDENCE & PREVALENCE OF ULCERATIVE COLITIS IN JAPAN (2018 – 2027)
Exhibit 35: COMPARATIVE ANALYSIS OF INCIDENCE & PREVALENCE OF ULCERATIVE COLITIS IN JAPAN (2018 – 2020)
Exhibit 36: COMPARATIVE ANALYSIS OF INCIDENCE & PREVALENCE OF ULCERATIVE COLITIS IN JAPAN (2021 – 2027)
Exhibit 37: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY DISEASE TYPE IN JAPAN (2018 – 2027)
Exhibit 38: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY SEVERITY TYPE IN JAPAN (2018 – 2027)
Exhibit 39: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY AGE GROUP IN JAPAN (2018 – 2027)
Exhibit 40: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY GENDER TYPE IN JAPAN (2018 – 2027)
Exhibit 41: HISTORIC & PROJECTED VOLUME OF PREVELANCE OF ULCERATIVE COLITIS BY DISEASE TYPE IN JAPAN (2018 – 2027)
Exhibit 42: HISTORIC & PROJECTED VOLUME OF PREVALENCE OF ULCERATIVE COLITIS BY SEVERITY TYPE IN JAPAN (2018 – 2027)
Exhibit 43: HISTORIC & PROJECTED VOLUME OF PREVALENCE OF ULCERATIVE COLITIS BY AGE GROUP IN JAPAN (2018 – 2027)
Exhibit 44: HISTORIC & PROJECTED VOLUME OF PREVALENCE OF ULCERATIVE COLITIS BY GENDER TYPE IN JAPAN (2018 – 2027)
Exhibit 45: HISTORIC & PROJECTED VOLUME OF INCIDENCE & PREVALENCE OF ULCERATIVE COLITIS IN GERMANY (2018 – 2027)
Exhibit 46: COMPARATIVE ANALYSIS OF INCIDENCE & PREVALENCE OF ULCERATIVE COLITIS IN GERMANY (2018 – 2020)
Exhibit 47: COMPARATIVE ANALYSIS OF INCIDENCE & PREVALENCE OF ULCERATIVE COLITIS IN GERMANY (2021 – 2027)
Exhibit 48: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY DISEASE TYPE IN GERMANY (2018 – 2027)
Exhibit 49: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY SEVERITY TYPE IN GERMANY (2018 – 2027)
Exhibit 50: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY AGE GROUP IN GERMANY (2018 – 2027)
Exhibit 51: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY GENDER TYPE IN GERMANY (2018 – 2027)
Exhibit 52: HISTORIC & PROJECTED VOLUME OF PREVELANCE OF ULCERATIVE COLITIS BY DISEASE TYPE IN GERMANY (2018 – 2027)
Exhibit 53: HISTORIC & PROJECTED VOLUME OF PREVALENCE OF ULCERATIVE COLITIS BY SEVERITY TYPE IN GERMANY (2018 – 2027)
Exhibit 54: HISTORIC & PROJECTED VOLUME OF PREVALENCE OF ULCERATIVE COLITIS BY AGE GROUP IN GERMANY (2018 – 2027)
Exhibit 55: HISTORIC & PROJECTED VOLUME OF PREVALENCE OF ULCERATIVE COLITIS BY GENDER TYPE IN GERMANY (2018 – 2027)
Exhibit 56: HISTORIC & PROJECTED VOLUME OF INCIDENCE & PREVALENCE OF ULCERATIVE COLITIS IN UK (2018 – 2027)
Exhibit 57: COMPARATIVE ANALYSIS OF INCIDENCE & PREVALENCE OF ULCERATIVE COLITIS IN UK (2018 – 2020)
Exhibit 58: COMPARATIVE ANALYSIS OF INCIDENCE & PREVALENCE OF ULCERATIVE COLITIS IN UK (2021 – 2027)
Exhibit 59: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY DISEASE TYPE IN UK (2018 – 2027)
Exhibit 60: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY SEVERITY TYPE IN UK (2018 – 2027)
Exhibit 61: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY AGE GROUP IN UK (2018 – 2027)
Exhibit 62: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY GENDER TYPE IN UK (2018 – 2027)
Exhibit 63: HISTORIC & PROJECTED VOLUME OF PREVELANCE OF ULCERATIVE COLITIS BY DISEASE TYPE IN UK (2018 – 2027)
Exhibit 64: HISTORIC & PROJECTED VOLUME OF PREVALENCE OF ULCERATIVE COLITIS BY SEVERITY TYPE IN UK (2018 – 2027)
Exhibit 65: HISTORIC & PROJECTED VOLUME OF PREVALENCE OF ULCERATIVE COLITIS BY AGE GROUP IN UK (2018 – 2027)
Exhibit 66: HISTORIC & PROJECTED VOLUME OF PREVALENCE OF ULCERATIVE COLITIS BY GENDER TYPE IN UK (2018 – 2027)
Exhibit 67: HISTORIC & PROJECTED VOLUME OF INCIDENCE & PREVALENCE OF ULCERATIVE COLITIS IN FRANCE (2018 – 2027)
Exhibit 68: COMPARATIVE ANALYSIS OF INCIDENCE & PREVALENCE OF ULCERATIVE COLITIS IN FRANCE (2018 – 2020)
Exhibit 69: COMPARATIVE ANALYSIS OF INCIDENCE & PREVALENCE OF ULCERATIVE COLITIS IN FRANCE (2021 – 2027)
Exhibit 70: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY DISEASE TYPE IN FRANCE (2018 – 2027)
Exhibit 71: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY SEVERITY TYPE IN FRANCE (2018 – 2027)
Exhibit 72: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY AGE GROUP IN FRANCE (2018 – 2027)
Exhibit 73: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY GENDER TYPE IN FRANCE (2018 – 2027)
Exhibit 74: HISTORIC & PROJECTED VOLUME OF PREVELANCE OF ULCERATIVE COLITIS BY DISEASE TYPE IN FRANCE (2018 – 2027)
Exhibit 75: HISTORIC & PROJECTED VOLUME OF PREVALENCE OF ULCERATIVE COLITIS BY SEVERITY TYPE IN FRANCE (2018 – 2027)
Exhibit 76: HISTORIC & PROJECTED VOLUME OF PREVALENCE OF ULCERATIVE COLITIS BY AGE GROUP IN FRANCE (2018 – 2027)
Exhibit 77: HISTORIC & PROJECTED VOLUME OF PREVALENCE OF ULCERATIVE COLITIS BY GENDER TYPE IN FRANCE (2018 – 2027)
Exhibit 78: HISTORIC & PROJECTED VOLUME OF INCIDENCE & PREVALENCE OF ULCERATIVE COLITIS IN ITALY (2018 – 2027)
Exhibit 79: COMPARATIVE ANALYSIS OF INCIDENCE & PREVALENCE OF ULCERATIVE COLITIS IN ITALY (2018 – 2020)
Exhibit 80: COMPARATIVE ANALYSIS OF INCIDENCE & PREVALENCE OF ULCERATIVE COLITIS IN ITALY (2021 – 2027)
Exhibit 81: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY DISEASE TYPE IN ITALY (2018 – 2027)
Exhibit 82: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY SEVERITY TYPE IN ITALY (2018 – 2027)
Exhibit 83: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY AGE GROUP IN ITALY (2018 – 2027)
Exhibit 84: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY GENDER TYPE IN ITALY (2018 – 2027)
Exhibit 85: HISTORIC & PROJECTED VOLUME OF PREVELANCE OF ULCERATIVE COLITIS BY DISEASE TYPE IN ITALY (2018 – 2027)
Exhibit 86: HISTORIC & PROJECTED VOLUME OF PREVALENCE OF ULCERATIVE COLITIS BY SEVERITY TYPE IN ITALY (2018 – 2027)
Exhibit 87: HISTORIC & PROJECTED VOLUME OF PREVALENCE OF ULCERATIVE COLITIS BY AGE GROUP IN ITALY (2018 – 2027)
Exhibit 88: HISTORIC & PROJECTED VOLUME OF PREVALENCE OF ULCERATIVE COLITIS BY GENDER TYPE IN ITALY (2018 – 2027)
Exhibit 89: HISTORIC & PROJECTED VOLUME OF INCIDENCE & PREVALENCE OF ULCERATIVE COLITIS IN SPAIN (2018 – 2027)
Exhibit 90: COMPARATIVE ANALYSIS OF INCIDENCE & PREVALENCE OF ULCERATIVE COLITIS IN SPAIN (2018 – 2020)
Exhibit 91: COMPARATIVE ANALYSIS OF INCIDENCE & PREVALENCE OF ULCERATIVE COLITIS IN SPAIN (2021 – 2027)
Exhibit 92: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY DISEASE TYPE IN SPAIN (2018 – 2027)
Exhibit 93: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY SEVERITY TYPE IN SPAIN (2018 – 2027)
Exhibit 94: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY AGE GROUP IN SPAIN (2018 – 2027)
Exhibit 95: HISTORIC & PROJECTED VOLUME OF INCIDENCE OF ULCERATIVE COLITIS BY GENDER TYPE IN SPAIN (2018 – 2027)
Exhibit 96: HISTORIC & PROJECTED VOLUME OF PREVELANCE OF ULCERATIVE COLITIS BY DISEASE TYPE IN SPAIN (2018 – 2027)
Exhibit 97: HISTORIC & PROJECTED VOLUME OF PREVALENCE OF ULCERATIVE COLITIS BY SEVERITY TYPE IN SPAIN (2018 – 2027)
Exhibit 98: HISTORIC & PROJECTED VOLUME OF PREVALENCE OF ULCERATIVE COLITIS BY AGE GROUP IN SPAIN (2018 – 2027)
Exhibit 99: HISTORIC & PROJECTED VOLUME OF PREVALENCE OF ULCERATIVE COLITIS BY GENDER TYPE IN SPAIN (2018 – 2027)
Exhibit 100: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET IN 8 MAJOR MARKETS (2021 – 2027)
Exhibit 101: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET SNAPSHOT IN 8 MAJOR MARKETS (2018 – 2020)
Exhibit 102: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET BY DISEASE TYPE IN 8 MAJOR MARKETS (2021 – 2027)
Exhibit 103: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET BY GENDER TYPE IN 8 MAJOR MARKETS (2021 – 2027)
Exhibit 104: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET BY DRUG CLASS IN 8 MAJOR MARKETS (2021 – 2027)
Exhibit 105: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET IN US (2021 – 2027)
Exhibit 106: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET SNAPSHOT IN US (2018 – 2020)
Exhibit 107: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET BY DISEASE TYPE IN US (2021 – 2027)
Exhibit 108: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET BY GENDER TYPE IN US (2021 – 2027)
Exhibit 109: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET BY DRUG CLASS IN US (2021 – 2027)
Exhibit 110: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET IN CHINA (2021 – 2027)
Exhibit 111: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET SNAPSHOT IN CHINA (2018 – 2020)
Exhibit 112: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET BY DISEASE TYPE IN CHINA (2021 – 2027)
Exhibit 113: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET BY GENDER TYPE IN CHINA (2021 – 2027)
Exhibit 114: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET BY DRUG CLASS IN CHINA (2021 – 2027)
Exhibit 115: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET IN GERMANY (2021 – 2027)
Exhibit 116: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET SNAPSHOT IN GERMANY (2018 – 2020)
Exhibit 117: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET BY DISEASE TYPE IN GERMANY (2021 – 2027)
Exhibit 118: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET BY GENDER TYPE IN GERMANY (2021 – 2027)
Exhibit 119: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET BY DRUG CLASS IN GERMANY (2021 – 2027)
Exhibit 120: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET IN JAPAN (2021 – 2027)
Exhibit 121: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET SNAPSHOT IN JAPAN (2018 – 2020)
Exhibit 122: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET BY DISEASE TYPE IN JAPAN (2021 – 2027)
Exhibit 123: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET BY GENDER TYPE IN JAPAN (2021 – 2027)
Exhibit 124: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET BY DRUG CLASS IN JAPAN (2021 – 2027)
Exhibit 125: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET IN FRANCE (2021 – 2027)
Exhibit 126: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET SNAPSHOT IN FRANCE (2018 – 2020)
Exhibit 127: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET BY DISEASE TYPE IN FRANCE (2021 – 2027)
Exhibit 128: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET BY GENDER TYPE IN FRANCE (2021 – 2027)
Exhibit 129: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET BY DRUG CLASS IN FRANCE (2021 – 2027)
Exhibit 130: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET IN ITALY (2021 – 2027)
Exhibit 131: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET SNAPSHOT IN ITALY (2018 – 2020)
Exhibit 132: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET BY DISEASE TYPE IN ITALY (2021 – 2027)
Exhibit 133: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET BY GENDER TYPE IN ITALY (2021 – 2027)
Exhibit 134: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET BY DRUG CLASS IN ITALY (2021 – 2027)
Exhibit 135: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET IN UK (2021 – 2027)
Exhibit 136: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET SNAPSHOT IN UK (2018 – 2020)
Exhibit 137: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET BY DISEASE TYPE IN UK (2021 – 2027)
Exhibit 138: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET BY GENDER TYPE IN UK (2021 – 2027)
Exhibit 139: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET BY DRUG CLASS IN UK (2021 – 2027)
Exhibit 140: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET IN SPAIN (2021 – 2027)
Exhibit 141: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET SNAPSHOT IN SPAIN (2018 – 2020)
Exhibit 142: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET BY DISEASE TYPE IN SPAIN (2021 – 2027)
Exhibit 143: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET BY GENDER TYPE IN SPAIN (2021 – 2027)
Exhibit 144: HISTORIC & PROJECTED REVENUE OF ULCERATIVE COLITIS THERAPEUTICS MARKET BY DRUG CLASS IN SPAIN (2021 – 2027)
Exhibit 145: MARKETED DRUGS OVERVIEW IN ULCERATIVE COLITIS THERAPEUTICS MARKET
Exhibit 146: MARKETED DRUGS OVERVIEW SNAPSHOT IN ULCERATIVE COLITIS THERAPEUTICS MARKET
Exhibit 147: PIPELINE DRUGS OVERVIEW IN ULCERATIVE COLITIS THERAPEUTICS MARKET
Exhibit 148: ULCERATIVE COLITIS PIPELINE DRUGS OVERVIEW BY DISEASE TYPE
Exhibit 149: ULCERATIVE COLITIS PIPELINE DRUGS OVERVIEW BY DEVELOPMENT PHASE
Exhibit 150: ULCERATIVE COLITIS PIPELINE DRUGS OVERVIEW BY ROUTE OF ADMINISTRATION
Exhibit 151: ULCERATIVE COLITIS PIPELINE DRUGS OVERVIEW BY MECHANISM OF ACTION
Exhibit 152: ULCERATIVE COLITIS PIPELINE DRUGS OVERVIEW BY MOLECULE TYPE
Exhibit 153: ULCERATIVE COLITIS PIPELINE DRUGS OVERVIEW BY GEOGRAPHY TYPE
Exhibit 154: ULCERATIVE COLITIS CLINICAL TRIAL ANALYSIS SNAPSHOT
Exhibit 155: ULCERATIVE COLITIS CLINICAL TRIAL ANALYSIS SNAPSHOT BY RECRUITMENT STATUS
Exhibit 156: ULCERATIVE COLITIS CLINICAL TRIAL ANALYSIS SNAPSHOT BY PRODUCT TYPE
Exhibit 157: ULCERATIVE COLITIS CLINICAL TRIAL ANALYSIS SNAPSHOT BY ROUTE OF ADMINISTRATION
Exhibit 158: ULCERATIVE COLITIS CLINICAL TRIAL ANALYSIS SNAPSHOT BY MOLECULE TYPE
Exhibit 159: ULCERATIVE COLITIS CLINICAL TRIAL ANALYSIS SNAPSHOT BY GEOGRAPHY TYPE
Exhibit 160: COMPETITIVE ASSESSMENT OF ULCERATIVE COLITIS THERAPEUTICS MARKET
TABLES
Table 1: KEY MARKET DRIVERS IN ULCERATIVE COLITIS THERAPEUTICS MARKET
Table 2: KEY MARKET CONSTRAINTS IN ULCERATIVE COLITIS THERAPEUTICS MARKET
Table 3: KEY MARKET TRENDS IN ULCERATIVE COLITIS THERAPEUTICS MARKET
Table 4: KEY TENTATIVE TIMELINE APPROVALS OF PIPELINE DRUHS IN ULCERATIVE COLITIS
Table 5: KEY REGULATORY DESIGNATIONS OF PIPELINE DRUHS IN ULCERATIVE COLITIS
Table 6: KEY MILESTONES IN ULCERATIVE COLITIS THERAPEUTICS MARKET
Table 7: KEY DEALS & COLLABORATIONS IN ULCERATIVE COLITIS THERAPEUTICS MARKET
Table 8: KEY INACTIVE/DISCONTINUED PRODUCTS IN ULCERATIVE COLITIS THERAPEUTICS MARKET